In concordance with our study, the overexpression of CDK9 and its prognostic value have been documented in several human cancers, including endometrial cancer, chordoma, osteosarcoma, pancreatic cancer and colon cancer [19, 26, 27, 33, 34]. This evidence concerns the gene CDK9 and familial pancreatic carcinoma.